Member of the Health Commission: Obstacles to the export of drugs must be removed.
Razzadeh, a member of the parliament's health committee, emphasized the ability of Iran's pharmaceutical industry to be present in regional markets.
Complex bureaucracy and changing decisions can reduce the competitiveness of local pharmaceutical companies and make their export path difficult.
The entire capacity of the pharmaceutical industry should not be wasted on producing duplicate items; Instead, more support should be given to knowledge-based companies active in the field of manufacturing new drugs, raw materials and advanced technologies.